Canada gains access to first shingles vaccine
This article was originally published in Scrip
Executive Summary
Health Canadahas approved Merck Frosst Canada's shingles vaccine Zostavax (varicella vaccine) for patients aged 60 years or older, making it the first vaccine for the prevention of shingles (herpes zoster) available in the country.